Novo plant acquired in Catalent buyout faces renewed FDA scrutiny with Form 483: STAT
22nd August 2025 Uncategorised 0Despite boasting a new owner, the Indiana manufacturing plant that Novo Nordisk picked up as part of its parent company’s Catalent buyout last year continues to catch flak from the FDA.
More: Novo plant acquired in Catalent buyout faces renewed FDA scrutiny with Form 483: STAT
Source: fierce